PPARG, peroxisome proliferator activated receptor gamma, 5468
N. diseases: 877; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 12318995 | intron variant | C/T | snv | 2.8E-02 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
1.000 | 0.040 | 3 | 12308425 | intron variant | T/C | snv | 0.28 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12327902 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 12327902 | intron variant | C/T | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 12379557 | intron variant | G/T | snv | 3.3E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 12379557 | intron variant | G/T | snv | 3.3E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 3 | 12288284 | intron variant | C/T | snv | 8.8E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 3 | 12288912 | 5 prime UTR variant | G/A | snv | 1.1E-02 |
|
Digestive System Diseases; Chemically-Induced Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 3 | 12288912 | 5 prime UTR variant | G/A | snv | 1.1E-02 |
|
Digestive System Diseases; Chemically-Induced Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 3 | 12299426 | intron variant | T/C | snv | 4.0E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12343100 | intron variant | T/C;G | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 12343100 | intron variant | T/C;G | snv | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.040 | 3 | 12347814 | intron variant | A/G | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12348985 | intron variant | T/C | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 3 | 12348985 | intron variant | T/C | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12348985 | intron variant | T/C | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 3 | 12304472 | intron variant | C/A;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 3 | 12428740 | intron variant | A/C | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 3 | 12428740 | intron variant | A/C | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.160 | 3 | 12353341 | intron variant | C/T | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 3 | 12293492 | intron variant | G/A | snv | 0.59 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
3 | 12337852 | intron variant | A/G | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |